CN112805011A - 抗乙型肝炎病毒剂 - Google Patents

抗乙型肝炎病毒剂 Download PDF

Info

Publication number
CN112805011A
CN112805011A CN201980065222.2A CN201980065222A CN112805011A CN 112805011 A CN112805011 A CN 112805011A CN 201980065222 A CN201980065222 A CN 201980065222A CN 112805011 A CN112805011 A CN 112805011A
Authority
CN
China
Prior art keywords
hepatitis
virus
fluoro
group
examples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980065222.2A
Other languages
English (en)
Chinese (zh)
Inventor
滨田智仁
岸川洋介
稻生佳菜子
池田正德
武田绿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daikin Industries Ltd
Kagoshima University NUC
Original Assignee
Daikin Industries Ltd
Kagoshima University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikin Industries Ltd, Kagoshima University NUC filed Critical Daikin Industries Ltd
Priority claimed from PCT/JP2019/038246 external-priority patent/WO2020071283A1/ja
Publication of CN112805011A publication Critical patent/CN112805011A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201980065222.2A 2018-10-04 2019-09-27 抗乙型肝炎病毒剂 Pending CN112805011A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2018189216 2018-10-04
JP2018-189216 2018-10-04
JP2019-078616 2019-04-17
JP2019078616A JP7378764B2 (ja) 2018-10-04 2019-04-17 抗ｂ型肝炎ウイルス剤
PCT/JP2019/038246 WO2020071283A1 (ja) 2018-10-04 2019-09-27 抗ｂ型肝炎ウイルス剤

Publications (1)

Publication Number Publication Date
CN112805011A true CN112805011A (zh) 2021-05-14

Family

ID=70218775

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980065222.2A Pending CN112805011A (zh) 2018-10-04 2019-09-27 抗乙型肝炎病毒剂

Country Status (2)

Country Link
JP (1) JP7378764B2 (ja)
CN (1) CN112805011A (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014352A1 (en) * 1989-05-23 1990-11-29 Southern Research Institute 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives
WO2017155082A1 (ja) * 2016-03-11 2017-09-14 国立大学法人鹿児島大学 抗肝腫瘍ウイルス剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014352A1 (en) * 1989-05-23 1990-11-29 Southern Research Institute 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives
WO2017155082A1 (ja) * 2016-03-11 2017-09-14 国立大学法人鹿児島大学 抗肝腫瘍ウイルス剤

Also Published As

Publication number Publication date
JP7378764B2 (ja) 2023-11-14
JP2020059692A (ja) 2020-04-16

Similar Documents

Publication Publication Date Title
US10076533B2 (en) Acyclic nucleoside phosphonate diesters
US7582748B2 (en) Methods of manufacture of 2′-deoxy-β-L-nucleosides
CA2904692A1 (en) Modified 4'-nucleosides as antiviral agents
JP2017057200A (ja) 抗ｄｎａウィルス活性などの生理活性を有するヌクレオシド誘導体
WO2020213501A1 (ja) 核酸アナログ及び抗ｂ型肝炎ウイルス剤
CN111655691A (zh) 肝递送恩替卡韦前体药物核苷环磷酸酯化合物及应用
JP2001515900A (ja) 抗ウイルス薬
JPWO2020045628A1 (ja) 核酸アナログ及び抗ｂ型肝炎ウイルス剤
CN112805011A (zh) 抗乙型肝炎病毒剂
RU2347786C2 (ru) Производные сложноэфирных липидов нуклеотидов
EP3862004A1 (en) Anti-hepatitis b virus agent
JP7378760B2 (ja) 抗ｂ型肝炎ウイルス剤
EP0461815A1 (en) Anti-HBV pyrimidine nucleoside
WO2020158951A1 (ja) 抗ｃ型肝炎ウイルス剤
US20120309705A1 (en) Novel 3'-deoxy-3'-methylidene-beta-l-nucleosides
JP2020164521A (ja) 抗ウィルス薬
WO2018110643A1 (ja) 抗ウイルス活性を示すヌクレオシド誘導体
JP2015113285A (ja) 抗ｂ型肝炎ウイルス薬

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination